What is the appropriate management for a patient with a heart rate of 140 beats per minute?

Management of Heart Rate 140 bpm

The immediate priority is determining hemodynamic stability and identifying the underlying rhythm—if the patient is hemodynamically unstable with HR 140, proceed directly to electrical cardioversion; if stable, the specific rhythm dictates management, with IV beta blockers or nondihydropyridine calcium channel blockers as first-line for most supraventricular tachycardias without pre-excitation.

Initial Assessment Algorithm

Assess hemodynamic stability first:

• Check for hypotension, altered mental status, acute heart failure, ongoing chest pain/ischemia
• If ANY of these present → immediate synchronized cardioversion 1, 2

If hemodynamically stable, identify the rhythm:

• Obtain 12-lead ECG immediately
• Narrow QRS (<120ms) vs wide QRS (≥120ms)
• Regular vs irregular rhythm
• Look specifically for pre-excitation (delta waves, short PR)

Management by Rhythm Type

For Atrial Fibrillation/Flutter (Irregular Rhythm)

Acute rate control in stable patients:

• First-line: IV beta blocker OR IV diltiazem/verapamil (Class I recommendation) 1, 3
  • Metoprolol: 2.5-5 mg IV bolus over 2 minutes, up to 3 doses 1
  • Avoid nondihydropyridine calcium channel blockers if decompensated heart failure present 1
  • Avoid ALL AV nodal blockers (beta blockers, calcium channel blockers, digoxin, amiodarone) if pre-excitation/WPW present—these can precipitate ventricular fibrillation 1, 3

Target heart rate:

• Lenient control: <110 bpm at rest is reasonable if asymptomatic with preserved LV function (Class IIb) 1, 3, 4
• Stricter control (<80 bpm) reasonable for symptomatic patients (Class IIa) 1, 3
• Recent evidence suggests resting HR ≥100 bpm associated with increased heart failure and mortality risk 5, 6

Critical contraindications:

• Do NOT use digoxin, diltiazem, verapamil, or IV amiodarone in pre-excited AF (WPW)—use procainamide or ibutilide instead 1, 3
• Do NOT use nondihydropyridine calcium channel blockers in decompensated heart failure 1, 3

For Supraventricular Tachycardia (Regular Narrow Complex)

If AVNRT or AVRT suspected:

1. Vagal maneuvers first (Class I) 7

   • Modified Valsalva (bearing down 10-30 seconds at 30-40 mmHg pressure)
   • Carotid massage (after confirming no bruit, 5-10 seconds)
   • Ice-cold towel to face

2. If vagal maneuvers fail: IV adenosine (Class I) 7

   • Avoid in severe bronchial asthma 8

3. If adenosine fails or contraindicated: IV beta blocker, diltiazem, or verapamil (Class IIa) 7

4. If all pharmacologic measures fail: IV amiodarone (Class IIb) 7

5. Last resort: synchronized cardioversion (Class I) 7

For Sinus Tachycardia

Do NOT treat the heart rate—treat the underlying cause 8:

• Hypoxia, hypovolemia, anemia, fever, pain
• Hyperthyroidism, pulmonary embolism
• Medications (stimulants, bronchodilators)
• Myocardial ischemia

Sinus tachycardia at 140 bpm is physiologic response; suppressing it without addressing the cause is harmful.

For Wide Complex Tachycardia (QRS ≥120ms)

Assume ventricular tachycardia until proven otherwise:

• If hemodynamically unstable → immediate cardioversion 8, 2
• If stable and DEFINITELY supraventricular → manage as narrow complex
• If uncertain → IV procainamide or amiodarone 8, 2
• Never use verapamil for wide complex tachycardia of unknown etiology

Special Populations

Acute Coronary Syndrome:

• IV beta blockers preferred if no heart failure/hemodynamic instability (Class I) 3
• Avoid nondihydropyridine calcium channel blockers unless no heart failure 3
• Urgent cardioversion if hemodynamic compromise or ongoing ischemia 3

Heart Failure with Reduced Ejection Fraction:

• Beta blockers or digoxin preferred (Class I) 3
• IV amiodarone acceptable for rate control in critically ill 3
• Avoid nondihydropyridine calcium channel blockers 3

Hypertrophic Cardiomyopathy:

• Beta blockers or nondihydropyridine calcium channel blockers (Class IIa) 3
• Avoid digoxin (increases outflow gradient) 3

COPD/Pulmonary Disease:

• Nondihydropyridine calcium channel blockers preferred (Class I) 3
• Beta blockers generally avoided, though metoprolol used successfully in select cases after correcting hypoxia 7

Common Pitfalls

1. Missing pre-excitation: Always check for delta waves before giving AV nodal blockers in AF—can be fatal
2. Treating sinus tachycardia: HR 140 in sinus rhythm demands finding the underlying cause, not rate suppression
3. Using calcium channel blockers in heart failure: Worsens hemodynamics in decompensated HF
4. Inadequate rate control targets: Recent data suggests rates ≥100 bpm increase mortality risk 5, 6, though guidelines allow lenient control <110 bpm 4
5. Assuming wide complex is SVT: Treat as VT unless proven otherwise to avoid catastrophic outcomes